Vasopressin V1a receptor — Drug Target

All drugs that target Vasopressin V1a receptor — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

atosiban · Vasopressin V1a receptor antagonist

Marketed (1)

• Antocin Ii · Ferring Pharmaceuticals A/S · atosiban · Other

Phase 3 pipeline (1)

• NPSP558 · Shire · Vasopressin V1a receptor antagonist · Cardiovascular
  NPSP558 is a selective vasopressin V1a receptor antagonist that blocks vasopressin signaling to reduce aquaporin-2 water channel expression and increase urine output.

Phase 2 pipeline (1)

• Octapressin · Pain
  Octapressin works by binding to the vasopressin V1a receptor, which blocks pain signals to the brain.